Gordon Solomon Rosenberg, MD
Obstetrics/Gynecology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Looking this up.
Hospitals listed: Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rosenberg’s office at (408) 356-0431 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G65167 · Current
Licensed to practise in California · since 1989 · expires 2028-05-31 · Mount Sinai School of Medicine of New York University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$27,645
Medicare paid this office $27,645 for 188 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 90 | $9,691 | $77 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 74 | $3,544 | $48 |
| New patient visit (45+ min) | 18 | $2,699 | $150 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 21 | $2,534 | $121 |
| New patient visit (30+ min) | 25 | $2,504 | $100 |
See all 6 services
| Short return visit (20+ min) | 90 | $9,691 | $77 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 74 | $3,544 | $48 |
| New patient visit (45+ min) | 18 | $2,699 | $150 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 21 | $2,534 | $121 |
| New patient visit (30+ min) | 25 | $2,504 | $100 |
| Return visit (30+ min) | 16 | $1,910 | $119 |
Who their Medicare patients are
188 Original Medicare patients in 2024. Average age 73 · Under 65 7% · 85 and older 6% · Women 100% · Health risk score 0.83. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 57% · Depression 20% · Coronary heart disease 19% · Diabetes 15% · Chronic kidney disease 13% · Cancer 12% · Atrial fibrillation 10% · COPD 8% · Heart failure 7%.
The office billed $122,589, Medicare allowed $36,324 and paid $27,645; for 329 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 188 | 329 | 73 | 0.83 | $122,589 | $27,645 |
| 2023 | 212 | 352 | 74 | 0.75 | $110,253 | $26,998 |
| 2022 | 208 | 404 | 73 | 0.76 | $114,902 | $28,729 |
| 2021 | 192 | 359 | 73 | 0.83 | $118,195 | $27,197 |
| 2020 | 216 | 390 | 74 | 0.91 | $145,686 | $28,371 |
| 2019 | 260 | 515 | 73 | 0.72 | $220,583 | $40,934 |
| 2018 | 230 | 431 | 74 | 0.85 | $134,313 | $25,876 |
| 2017 | 221 | 404 | 73 | 0.79 | $96,439 | $20,623 |
| 2016 | 202 | 418 | 73 | 0.78 | $103,508 | $25,168 |
| 2015 | 266 | 729 | 72 | 0.80 | $95,586 | $35,445 |
| 2014 | 293 | 777 | 72 | 0.75 | $73,978 | $40,298 |
| 2013 | 235 | 573 | 72 | 0.69 | $66,223 | $34,514 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Short return visit (20+ min) | 84 | $9,252 | $78 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 90 | $4,301 | $48 |
| New patient visit (45+ min) | 18 | $2,621 | $146 |
| Return visit (30+ min) | 19 | $2,125 | $112 |
| New patient visit (30+ min) | 20 | $1,835 | $92 |
| Complete ultrasound scan of pelvis | 15 | $1,680 | $112 |
| Influenza vaccine split virus, preservative free | 12 | $863 | $72 |
| Administration of influenza virus vaccine | 14 | $517 | $37 |
2022: 7 services
| Short return visit (20+ min) | 94 | $10,025 | $73 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 82 | $3,920 | $48 |
| New patient visit (30+ min) | 29 | $2,753 | $95 |
| Return visit (30+ min) | 20 | $2,262 | $113 |
| Complete ultrasound scan of pelvis | 16 | $1,810 | $106 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 43 | $765 | $18 |
| Administration of influenza virus vaccine | 12 | $447 | $37 |
2021: 8 services
| Short return visit (20+ min) | 77 | $7,828 | $78 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 85 | $4,183 | $49 |
| Return visit (30+ min) | 20 | $2,778 | $116 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 15 | $1,899 | $119 |
| New patient visit (30+ min) | 20 | $1,838 | $92 |
| Influenza vaccine split virus, preservative free | 12 | $783 | $65 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 28 | $505 | $18 |
| Administration of influenza virus vaccine | 15 | $329 | $22 |
2020: 8 services
| Short return visit (20+ min) | 89 | $6,635 | $63 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 87 | $4,268 | $49 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 25 | $3,018 | $121 |
| New patient visit (45+ min) | 20 | $2,726 | $136 |
| New patient visit (30+ min) | 28 | $2,670 | $95 |
| Return visit (30+ min) | 17 | $1,805 | $100 |
| Administration of influenza virus vaccine | 12 | $251 | $21 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 12 | $216 | $18 |
2019: 9 services
| Short return visit (20+ min) | 90 | $6,499 | $64 |
| New patient visit (45+ min) | 39 | $5,270 | $135 |
| Return visit (30+ min) | 52 | $5,165 | $91 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 101 | $4,793 | $47 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 33 | $4,464 | $124 |
| New patient visit (30+ min) | 23 | $2,109 | $92 |
| Influenza vaccine split virus, preservative free | 12 | $651 | $54 |
| Administration of influenza virus vaccine | 14 | $287 | $21 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 16 | $283 | $18 |
2018: 7 services
| Short return visit (20+ min) | 83 | $6,081 | $60 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 103 | $4,554 | $44 |
| New patient visit (45+ min) | 22 | $2,936 | $133 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 20 | $2,655 | $121 |
| Return visit (30+ min) | 20 | $2,106 | $92 |
| New patient visit (30+ min) | 13 | $1,183 | $91 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 51 | $982 | $19 |
2017: 6 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 123 | $5,649 | $46 |
| Short return visit (20+ min) | 56 | $4,985 | $62 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 13 | $1,813 | $113 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 81 | $1,732 | $21 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 22 | $1,223 | $56 |
| Short return visit | 14 | $448 | $32 |
2016: 8 services
| Short return visit (20+ min) | 74 | $6,799 | $63 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 106 | $4,804 | $45 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 51 | $2,823 | $55 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 14 | $1,682 | $120 |
| New patient visit (30+ min) | 14 | $1,163 | $83 |
| Return visit (30+ min) | 13 | $1,147 | $88 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 37 | $786 | $21 |
| Short return visit | 15 | $749 | $37 |
2015: 9 services
| Short return visit (20+ min) | 76 | $8,118 | $62 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 151 | $6,806 | $45 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 118 | $6,443 | $55 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 142 | $2,992 | $21 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 17 | $2,132 | $112 |
| New patient visit (45+ min) | 14 | $1,837 | $131 |
| Return visit (30+ min) | 19 | $1,565 | $78 |
| Dxa bone density measurement of hip, pelvis, spine | 22 | $1,152 | $52 |
| Manual urinalysis test with examination using microscope, non-automated | 16 | $131 | $4 |
2014: 11 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 170 | $9,098 | $54 |
| Short return visit (20+ min) | 96 | $7,402 | $57 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 169 | $7,351 | $43 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 99 | $2,084 | $21 |
| Dxa bone density measurement of hip, pelvis, spine | 33 | $2,024 | $61 |
| Return visit (30+ min) | 19 | $1,765 | $88 |
| New patient visit (45+ min) | 14 | $1,676 | $120 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 12 | $1,354 | $113 |
| New patient visit (30+ min) | 17 | $888 | $52 |
| Short return visit | 13 | $488 | $38 |
| Manual urinalysis test with examination using microscope, non-automated | 18 | $97 | $4 |
2013: 9 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 127 | $6,872 | $54 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 135 | $6,039 | $45 |
| Short return visit (20+ min) | 64 | $5,633 | $59 |
| Return visit (30+ min) | 30 | $2,726 | $83 |
| New patient visit (45+ min) | 17 | $2,303 | $135 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 18 | $1,211 | $67 |
| Dxa bone density measurement of hip, pelvis, spine | 13 | $819 | $63 |
| Short return visit | 11 | $348 | $29 |
| Manual urinalysis test with examination using microscope, non-automated | 14 | $77 | $4 |
Drugs they prescribed that Part D paid
$31,030
Pharmacies billed $31,030 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 304) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
249 generic and 55 brand-name prescriptions · $31,030 in drug cost · 26 antibiotic prescriptions to 20 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Premarin | 25 | $8,081 | $323 |
| Estradiol | 67 | $6,302 | $94 |
| Yuvafem | 14 | $2,285 | $163 |
| Valacyclovir | 18 | $1,125 | $62 |
| Estradiol (Twice Weekly) | 12 | $1,101 | $92 |
See all 12 drugs
| Premarin | 25 | $8,081 | $323 |
| Estradiol | 67 | $6,302 | $94 |
| Yuvafem | 14 | $2,285 | $163 |
| Valacyclovir | 18 | $1,125 | $62 |
| Estradiol (Twice Weekly) | 12 | $1,101 | $92 |
| Nitrofurantoin Mono-Macro | 18 | $466 | $26 |
| Clobetasol Propionate | 13 | $427 | $33 |
| Progesterone | 11 | $406 | $37 |
| Clotrimazole-Betamethasone | 16 | $322 | $20 |
| Alendronate | 15 | $297 | $20 |
| Zolpidem | 15 | $129 | $9 |
| Fluconazole | 13 | $83 | $6 |
Year by year
| 2024 | 304 | 118 | 0% (0) | 18% | $31,030 |
| 2023 | 315 | 130 | 0% (0) | 26% | $37,924 |
| 2022 | 277 | 104 | None | 22% | $30,232 |
| 2021 | 261 | 96 | None | 20% | $32,458 |
| 2020 | 348 | 105 | 0% (0) | 20% | $31,318 |
| 2019 | 371 | 118 | None | 30% | $39,646 |
| 2018 | 356 | 102 | 0% (0) | 29% | $38,164 |
| 2017 | 338 | 84 | 0% (0) | 33% | $46,849 |
| 2016 | 435 | 104 | None | 43% | $58,737 |
| 2015 | 511 | 107 | None | 46% | $60,852 |
| 2014 | 551 | 113 | None | 49% | $59,844 |
| 2013 | 544 | 100 | None | 49% | $50,708 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Premarin | 27 | $11,128 | $412 |
| Estradiol | 63 | $6,028 | $96 |
| Myrbetriq | 11 | $5,308 | $483 |
| Yuvafem | 14 | $2,678 | $191 |
| Estradiol (Twice Weekly) | 12 | $2,247 | $187 |
| Clobetasol Propionate | 22 | $883 | $40 |
| Valacyclovir | 13 | $713 | $55 |
| Clotrimazole-Betamethasone | 20 | $627 | $31 |
| Nitrofurantoin Mono-Macro | 22 | $557 | $25 |
| Alendronate | 11 | $188 | $17 |
| Zolpidem | 18 | $85 | $5 |
2022: 6 drugs
| Premarin | 24 | $9,608 | $400 |
| Estradiol | 53 | $5,161 | $97 |
| Clobetasol Propionate | 21 | $892 | $42 |
| Clotrimazole-Betamethasone | 22 | $478 | $22 |
| Nitrofurantoin Mono-Macro | 14 | $194 | $14 |
| Zolpidem | 20 | $181 | $9 |
2021: 6 drugs
| Premarin | 19 | $8,948 | $471 |
| Estradiol | 50 | $6,734 | $135 |
| Clobetasol Propionate | 19 | $1,171 | $62 |
| Zolpidem | 25 | $540 | $22 |
| Clotrimazole-Betamethasone | 14 | $382 | $27 |
| Nitrofurantoin Mono-Macro | 15 | $332 | $22 |
2020: 10 drugs
| Estradiol | 75 | $9,275 | $124 |
| Premarin | 17 | $5,659 | $333 |
| Osphena | 12 | $2,549 | $212 |
| Estradiol (Twice Weekly) | 13 | $2,325 | $179 |
| Nitrofurantoin Mono-Macro | 28 | $758 | $27 |
| Clotrimazole-Betamethasone | 24 | $710 | $30 |
| Clobetasol Propionate | 19 | $627 | $33 |
| Fluconazole | 20 | $283 | $14 |
| Zolpidem | 23 | $279 | $12 |
| Valacyclovir | 12 | $165 | $14 |
2019: 8 drugs
| Premarin | 36 | $11,954 | $332 |
| Estradiol | 86 | $9,275 | $108 |
| Osphena | 12 | $2,552 | $213 |
| Nitrofurantoin Mono-Macro | 32 | $931 | $29 |
| Valacyclovir | 16 | $672 | $42 |
| Clotrimazole-Betamethasone | 22 | $567 | $26 |
| Fluconazole | 18 | $278 | $15 |
| Zolpidem | 14 | $164 | $12 |
2018: 11 drugs
| Premarin | 33 | $11,004 | $333 |
| Yuvafem | 24 | $3,647 | $152 |
| Estradiol | 46 | $3,543 | $77 |
| Clobetasol Propionate | 15 | $838 | $56 |
| Progesterone | 12 | $769 | $64 |
| Nitrofurantoin Mono-Macro | 28 | $733 | $26 |
| Zolpidem | 18 | $449 | $25 |
| Estradiol-Norethindrone Acetat | 15 | $421 | $28 |
| Valacyclovir | 20 | $355 | $18 |
| Venlafaxine Hcl Er | 12 | $162 | $13 |
| Balziva | 13 | $127 | $10 |
2017: 13 drugs
| Premarin | 36 | $10,718 | $298 |
| Vesicare | 17 | $6,494 | $382 |
| Yuvafem | 23 | $4,821 | $210 |
| Vagifem | 13 | $4,282 | $329 |
| Estradiol | 37 | $3,040 | $82 |
| Combipatch | 11 | $2,067 | $188 |
| Nitrofurantoin Mono-Macro | 26 | $906 | $35 |
| Clobetasol Propionate | 12 | $857 | $71 |
| Zolpidem | 15 | $483 | $32 |
| Levothyroxine | 12 | $354 | $30 |
| Progesterone | 11 | $327 | $30 |
| Balziva | 13 | $172 | $13 |
| Valacyclovir | 16 | $77 | $5 |
2016: 13 drugs
| Premarin | 62 | $13,516 | $218 |
| Vagifem | 36 | $11,026 | $306 |
| Vesicare | 21 | $9,942 | $473 |
| Lexapro | 12 | $3,180 | $265 |
| Estradiol | 53 | $2,361 | $45 |
| Raloxifene | 17 | $1,848 | $109 |
| Combipatch | 12 | $1,761 | $147 |
| Nitrofurantoin Mono-Macro | 30 | $1,052 | $35 |
| Zolpidem | 19 | $980 | $52 |
| Levothyroxine | 11 | $330 | $30 |
| Heather | 11 | $288 | $26 |
| Valacyclovir | 11 | $115 | $10 |
| Ciprofloxacin | 11 | $80 | $7 |
2015: 18 drugs
| Premarin | 73 | $14,492 | $199 |
| Vagifem | 39 | $8,579 | $220 |
| Vesicare | 27 | $7,812 | $289 |
| Clobetasol Propionate | 31 | $5,273 | $170 |
| Prempro | 19 | $3,900 | $205 |
| Lexapro | 12 | $2,686 | $224 |
| Raloxifene | 11 | $1,997 | $182 |
| Estradiol | 37 | $1,616 | $44 |
| Vivelle-Dot | 12 | $1,171 | $98 |
| Nitrofurantoin Mono-Macro | 28 | $878 | $31 |
| Progesterone | 12 | $865 | $72 |
| Levothyroxine | 16 | $517 | $32 |
| Clotrimazole-Betamethasone | 17 | $411 | $24 |
| Heather | 13 | $374 | $29 |
| Fluconazole | 11 | $280 | $25 |
| Zolpidem | 14 | $251 | $18 |
| Medroxyprogesterone Acetate | 19 | $108 | $6 |
| Alendronate | 13 | $41 | $3 |
2014: 19 drugs
| Premarin | 65 | $10,673 | $164 |
| Tolterodine Tartrate Er | 20 | $7,382 | $369 |
| Vagifem | 55 | $6,814 | $124 |
| Vesicare | 16 | $4,702 | $294 |
| Prempro | 30 | $4,598 | $153 |
| Estradiol | 45 | $2,283 | $51 |
| Vivelle-Dot | 15 | $1,565 | $104 |
| Nitrofurantoin Mono-Macro | 23 | $1,066 | $46 |
| Ibandronate | 15 | $1,059 | $71 |
| Progesterone | 11 | $896 | $81 |
| Clotrimazole-Betamethasone | 18 | $609 | $34 |
| Clobetasol Propionate | 12 | $541 | $45 |
| Heather | 13 | $337 | $26 |
| Levothyroxine | 13 | $285 | $22 |
| Tri-Previfem | 13 | $192 | $15 |
| Zolpidem | 17 | $163 | $10 |
| Alendronate | 15 | $117 | $8 |
| Medroxyprogesterone Acetate | 11 | $62 | $6 |
| Ciprofloxacin | 13 | $48 | $4 |
2013: 18 drugs
| Detrol La | 32 | $11,101 | $347 |
| Premarin | 64 | $8,869 | $139 |
| Prempro | 36 | $5,520 | $153 |
| Vagifem | 43 | $4,107 | $96 |
| Desonide | 19 | $2,617 | $138 |
| Actonel | 13 | $1,829 | $141 |
| Valacyclovir | 30 | $1,260 | $42 |
| Estradiol | 58 | $952 | $16 |
| Nitrofurantoin Mono-Macro | 17 | $771 | $45 |
| Clotrimazole-Betamethasone | 11 | $362 | $33 |
| Heather | 12 | $350 | $29 |
| Alendronate | 19 | $233 | $12 |
| Clobetasol Propionate | 13 | $196 | $15 |
| Fluconazole | 11 | $176 | $16 |
| Zolpidem | 15 | $107 | $7 |
| Levothyroxine | 12 | $91 | $8 |
| Medroxyprogesterone Acetate | 14 | $89 | $6 |
| Ciprofloxacin | 13 | $47 | $4 |
Money from drug and device companies
$29 in 2025
| 2025 | 1 | 1 | None | $29 |
| 2024 | 2 | 8 | None | $74 |
| 2023 | 1 | 9 | None | $56 |
| 2021 | 1 | 1 | None | $22 |
| 2020 | 1 | 6 | None | $212 |
| 2019 | 3 | 7 | None | $227 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Hologic Sales and Service | Aptima | $29 | 1 payment
|
See the published payment
| Hologic Sales and Service | Meals · 2025-05-20 | Aptima | $29 |
See earlier years (2024, 2023, 2021, 2020, 2019)
2024: $74
| Mayne Pharma Commercial | None | $50 | 7 payments
|
| Hologic Sales and Service | Aptima | $25 | 1 payment
|
2023: $56
| Mayne Pharma Commercial | None | $56 | 9 payments
|
2021: $22
| AbbVie | Lo Loestrin Fe | $22 | 1 payment
|
2020: $212
| AbbVie | Orilissa | $212 | 6 payments
|
2019: $227
| AbbVie | Orilissa | $189 | 4 payments
|
| Allergan | Lo Loestrin Fe | $26 | 2 payments
|
| TherapeuticsMD | Imvexxy | $13 | 1 payment
|
Professional record
- NPI
- 1306806922
- Licence
- CA G65167California G65167: Current · expires 2028-05-31
- Trained
- Icahn School of Medicine at Mount Sinai, 1985
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 15151 National Ave, Los Gatos, CA, 95032
- NPI first listed
- 2006-03-27
- NPI last updated
- 2022-07-21
This is when the NPI record was last certified, not a medical board exam.